Publication Ethics and Malpractice Statement
Journal of Pharmacovigilance & Drug Safety Journal is dedicated to following the highest ethical principles of scholarly publishing and promoting highest standards of integrity and ethical conduct in research and its evaluation.
It is mandatory for authors, reviewers, and editorial board members to comply with "Publication Ethics and Malpractice Statement".
The Journal of Pharmacovigilance & Drug Safety is committed to following best practices on ethical matters, errors and retractions. The deterrence of publication malpractice is one of the important tasks of the editorial board. The International Archives of BioMedical and Clinical Research is very strict in any kind of unethical conduct, and will not tolerate plagiarism in any form. Authors should be assured before submitting articles to the Journal of Pharmacovigilance & Drug Safety that manuscript contents are original. Furthermore, they warrant that their article has neither been published elsewhere in any language fully or partly, nor is it under review for publication anywhere.
This journal would not be responsible for any dispute related to authorship of a submitted paper. Any change in the authorship (such as addition or deletion of author(s) or change in the sequence of author list) should be intimated to the editorial office through a letter signed by all authors before publication of the paper.
Journal of Pharmacovigilance & Drug Safety is determined to promote integrity in research publication. We have great respect and we generally follow the guidelines, given by COMMITTEE ON PUBLICATION ETHICS (COPE) for any publication disputes, authorship disputes, etc. For these kinds of disputes, we generally visit and follow the COPE website and author(s) are also requested to do so.
The authors give an exclusive unlimited license to Journal of Pharmacovigilance & Drug Safety to publish the accepted articles in any media (print, electronic or any other) any number of times. The authors should agree to transfer copyright and sign a declaration to this effect. The author(s) should be the sole author(s) of the article and should have full authority to enter into agreement and in granting rights to Journal of Pharmacovigilance & Drug Safety, which are not in breach of any other obligation. The author(s) should ensure the integrity of the paper and related works. Authors should mandatorily ensure that submission of manuscript to Journal of Pharmacovigilance & Drug Safety would result into no breach of contract or of confidence or of commitment given to secrecy.
The following duties outlined for editors, authors, and reviewers are based on the COPE Code of Conduct for Journal Editors. Editors, authors, and reviewers will also adhere to the Journal of Pharmacovigilance & Drug Safety submission guideline Policies.
DUTIES OF EDITOR
- Publication Decisions: Based on the review report of the editorial board, the editor can accept, reject, or request modifications to the manuscript.
- Review of Manuscripts: Editor must ensure that each manuscript is initially evaluated by the editor for originality, making use of appropriate software to do so. After passing this test, the manuscript is forwarded to two reviewers for single-blind peer review, each of whom will make a recommendation to accept, reject, or modify the manuscript. The review period will be up to 30 days.
- Fair Play: The editor must ensure that each manuscript received by the Journal is reviewed for its intellectual content without regard to sex, gender, race, religion, citizenship, etc. of the authors.
- Confidentiality: The editor must ensure that information regarding manuscripts submitted by the authors is kept confidential.
- Disclosure and Conflicts of Interest: The editor of the Journal will not use unpublished materials disclosed in a submitted manuscript for his own research without written consent of the author.
DUTIES OF AUTHORS
- Reporting Standards: Authors should present an accurate account of their original research as well as an objective discussion of its significance. Manuscripts will follow the submission guidelines of the journal.
- Originality: Authors must ensure that they have written entirely original work.
- Multiple, Redundant, or Concurrent Publications: Author should not submit the same manuscript to more than one journal concurrently. It is also expected that the author will not publish redundant manuscripts or manuscripts describing same research in more than one journal.
- Acknowledgement of Sources: Authors should acknowledge all sources of data used in the research and cite publications that have been influential in research work.
- Authorship of the Paper: Authorship should be limited to those who have made a significant contribution to conception, design, execution or interpretation of the reported study. Others who have made significant contribution must be listed as co-authors. Authors also ensure that all the authors have seen and agreed to the submitted version of the manuscript and their inclusion of names as co-authors.
- Data Access and Retention: Authors should provide raw data related to their manuscript for editorial review and must retain such data.
- Disclosure of Financial Support: Sources of financial support, if any, must be clearly disclosed.
- Fundamental Errors in Published Works: If at any point of time, author discovers a significant error or inaccuracy in submitted manuscript, then the error or inaccuracy must be reported to the editor.
DUTIES OF REVIEWERS
- Confidentiality: Information regarding manuscripts submitted by authors should be kept confidential and be treated as privileged information.
- Acknowledgement of Sources: Manuscript reviewers must ensure that authors have acknowledged all sources of data used in the research. Any kind of similarity or overlap between the manuscripts under consideration or with any other published paper of which reviewer has personal knowledge must be immediately brought to the editor's notice.
- Standards of Objectivity: Review of submitted manuscripts must be done objectively and the reviewers should express their views clearly with supporting arguments.
- Promptness: In the event that a reviewer feels it is not possible for him/her to complete review of manuscript within stipulated time then this information must be communicated to the editor, so that the manuscript could be sent to another reviewer.